Adherence to Endocrine Therapy and Racial Outcome Disparities in Breast Cancer.

ABSTRACT: The disparity in outcomes of breast cancer for Black compared with White women in the U.S. is well known and persistent over time, with the largest disparities appearing among women with hormone receptor-positive (HR+) cancers. The racial gap in breast cancer survival first emerged in the 1980s, a time of significantmen treatment advances in early-stage breast cancer, including the introduction of adjuvant endocrine therapy. Since that time, the gap has continued to widen despite steady advances in treatment and survival of breast cancer overall. Although advanced stage at presentation and unfavorable biology undoubtedly contribute to racial differences in survival of HR+ breast, treatment disparities are increasingly acknowledged to play a key role as well. The recent recognition of racia

SUBMITTER: Reeder-Hayes KE 

PROVIDER: S-EPMC8571754 | biostudies-literature | 2021 Nov

REPOSITORIES: biostudies-literature